SA Transcripts • Jun. 11, 2008
We currently have no Breaking News on this stock.
ACEL vs. ETF Alternatives
Tamir Biotechnology, Inc. (formerly Alfacell Corporation) is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges... More
Other News & PR